Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Prices
Biotech
US price negotiations could hit R&D harder than expected: study
A team at the University of Chicago found lower R&D spending could result in 79 fewer new small-molecule drugs over the next 20 years.
Nick Paul Taylor
Sep 6, 2023 10:20am
'On our minds': Novartis, GSK mull IRA impact on R&D strategies
Jul 26, 2023 11:06am
Biotechs lobby for their identity as drug pricing reforms set in
Jun 28, 2023 7:00am
VC firms, biotechs push back on drug pricing reforms
Jul 25, 2022 11:07am
Coalition urges NIH to disclose cost of federally-funded trials
Feb 1, 2022 10:08am
Drug price cuts could hit biopharma R&D: report
Apr 9, 2021 9:10am